Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
GDUFA III: First-Cycle Approval, Priority Assessment Improvements Are Early Priorities
Nov 03 2020
•
By
Derrick Gingery
GDUFA III negotiations include discussions of the pre-submission facility correspondence program, a prerequisite for a priority assessment. • Source: Shutterstock
More from Generics
More from Biosimilars & Generics